{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:50:55Z","timestamp":1754110255947,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":47,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071633656"},{"type":"electronic","value":"9781071633663"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-3366-3_14","type":"book-chapter","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T14:03:17Z","timestamp":1692626597000},"page":"229-247","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of Differential TLR Activation in a Mouse Model of Multiple Sclerosis"],"prefix":"10.1007","author":[{"given":"Chiara","family":"Suvieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Volpi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,22]]},"reference":[{"key":"14_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ncl.2017.08.002","volume":"36","author":"HN Lemus","year":"2018","unstructured":"Lemus HN, Warrington AE, Rodriguez M (2018) Multiple sclerosis: mechanisms of disease and strategies for myelin and axonal repair. Neurol Clin 36:1\u201311","journal-title":"Neurol Clin"},{"key":"14_CR2","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2174\/157015911796557911","volume":"9","author":"I Loma","year":"2011","unstructured":"Loma I, Heyman R (2011) Multiple sclerosis: pathogenesis and treatment. Curr Neuropharmacol 9:409\u2013416","journal-title":"Curr Neuropharmacol"},{"key":"14_CR3","first-page":"296","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik K et al (2022) Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science (1979) 375:296\u2013301","journal-title":"Science (1979)"},{"key":"14_CR4","doi-asserted-by":"publisher","first-page":"577313","DOI":"10.1016\/j.jneuroim.2020.577313","volume":"346","author":"H Keyvani","year":"2020","unstructured":"Keyvani H et al (2020) The role of human herpesvirus-6 and inflammatory markers in the pathogenesis of multiple sclerosis. J Neuroimmunol 346:577313","journal-title":"J Neuroimmunol"},{"key":"14_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ddmod.2020.02.003","volume":"32","author":"D Donati","year":"2020","unstructured":"Donati D (2020) Viral infections and multiple sclerosis. Drug Discov Today Dis Models 32:27\u201333","journal-title":"Drug Discov Today Dis Models"},{"key":"14_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00284-022-03112-z","volume":"80","author":"S Sedighi","year":"2023","unstructured":"Sedighi S et al (2023) Comprehensive investigations relationship between viral infections and multiple sclerosis pathogenesis. Curr Microbiol 80:15","journal-title":"Curr Microbiol"},{"key":"14_CR7","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1177\/1352458518823940","volume":"25","author":"M Marrodan","year":"2019","unstructured":"Marrodan M, Alessandro L, Farez MF, Correale J (2019) The role of infections in multiple sclerosis. Mult Scler 25:891\u2013901","journal-title":"Mult Scler"},{"key":"14_CR8","doi-asserted-by":"publisher","first-page":"777606","DOI":"10.3389\/fimmu.2021.777606","volume":"12","author":"H Li","year":"2021","unstructured":"Li H et al (2021) Role of toll-like receptors in neuroimmune diseases: therapeutic targets and problems. Front Immunol 12:777606","journal-title":"Front Immunol"},{"key":"14_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00401-016-1631-4","volume":"133","author":"H Lassmann","year":"2017","unstructured":"Lassmann H, Bradl M (2017) Multiple sclerosis: experimental models and reality. Acta Neuropathol 133:223\u2013244","journal-title":"Acta Neuropathol"},{"key":"14_CR10","doi-asserted-by":"publisher","first-page":"1019877","DOI":"10.3389\/fnmol.2022.1019877","volume":"15","author":"E Melamed","year":"2022","unstructured":"Melamed E, Palmer JL, Fonken C (2022) Advantages and limitations of experimental autoimmune encephalomyelitis in breaking down the role of the gut microbiome in multiple sclerosis. Front Mol Neurosci 15:1019877","journal-title":"Front Mol Neurosci"},{"key":"14_CR11","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1038\/nprot.2006.284","volume":"1","author":"IM Stromnes","year":"2006","unstructured":"Stromnes IM, Goverman JM (2006) Passive induction of experimental allergic encephalomyelitis. Nat Protoc 1:1952\u20131960","journal-title":"Nat Protoc"},{"key":"14_CR12","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1002\/eji.200425842","volume":"35","author":"PA Smith","year":"2005","unstructured":"Smith PA et al (2005) Native myelin oligodendrocyte glycoprotein promotes severe chronic neurological disease and demyelination in Biozzi ABH mice. Eur J Immunol 35:1311\u20131319","journal-title":"Eur J Immunol"},{"key":"14_CR13","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1084\/jem.20021603","volume":"197","author":"E Bettelli","year":"2003","unstructured":"Bettelli E et al (2003) Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med 197:1073\u20131081","journal-title":"J Exp Med"},{"key":"14_CR14","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S1074-7613(00)80562-2","volume":"8","author":"CJ Harrington","year":"1998","unstructured":"Harrington CJ et al (1998) Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein. Immunity 8:571\u2013580","journal-title":"Immunity"},{"key":"14_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1750-3639.2001.tb00385.x","volume":"11","author":"GK Matsushima","year":"2001","unstructured":"Matsushima GK, Morell P (2001) The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11:107\u2013116","journal-title":"Brain Pathol"},{"key":"14_CR16","first-page":"52679","volume":"97","author":"MB Keough","year":"2015","unstructured":"Keough MB, Jensen SK, Wee Yong V (2015) Experimental demyelination and remyelination of murine spinal cord by focal injection of lysolecithin. J Vis Exp 97:52679","journal-title":"J Vis Exp"},{"key":"14_CR17","doi-asserted-by":"publisher","first-page":"109303","DOI":"10.1016\/j.celrep.2021.109303","volume":"35","author":"KE Marks","year":"2021","unstructured":"Marks KE et al (2021) Toll-like receptor 2 induces pathogenicity in Th17 cells and reveals a role for IPCEF in regulating Th17 cell migration. Cell Rep 35:109303","journal-title":"Cell Rep"},{"key":"14_CR18","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12974-019-1540-2","volume":"16","author":"NJ Wasko","year":"2019","unstructured":"Wasko NJ et al (2019) Systemic TLR2 tolerance enhances central nervous system remyelination. J Neuroinflammation 16:158","journal-title":"J Neuroinflammation"},{"key":"14_CR19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/imm.12872","volume":"154","author":"TB Ferreira","year":"2018","unstructured":"Ferreira TB et al (2018) Different interleukin-17-secreting Toll-like receptor + T-cell subsets are associated with disease activity in multiple sclerosis. Immunology 154:239\u2013252","journal-title":"Immunology"},{"key":"14_CR20","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1093\/jnen\/61.11.1013","volume":"61","author":"M Bsibsi","year":"2002","unstructured":"Bsibsi M, Ravid R, Gveric D, van Noort JM (2002) Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 61:1013\u20131021","journal-title":"J Neuropathol Exp Neurol"},{"key":"14_CR21","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/cei.13150","volume":"193","author":"M Fujiwara","year":"2018","unstructured":"Fujiwara M et al (2018) Enhanced TLR2 responses in multiple sclerosis. Clin Exp Immunol 193:313\u2013326","journal-title":"Clin Exp Immunol"},{"key":"14_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.it.2005.03.012","volume":"26","author":"MK Racke","year":"2005","unstructured":"Racke MK, Hu W, Lovett-Racke AE (2005) PTX cruiser: driving autoimmunity via TLR4. Trends Immunol 26:289\u2013291","journal-title":"Trends Immunol"},{"key":"14_CR23","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/1742-2094-9-248","volume":"9","author":"RJ Mellanby","year":"2012","unstructured":"Mellanby RJ et al (2012) TLR-4 ligation of dendritic cells is sufficient to drive pathogenic T cell function in experimental autoimmune encephalomyelitis. J Neuroinflammation 9:248","journal-title":"J Neuroinflammation"},{"key":"14_CR24","doi-asserted-by":"publisher","first-page":"13064","DOI":"10.1073\/pnas.1120585109","volume":"109","author":"JM Reynolds","year":"2012","unstructured":"Reynolds JM, Martinez GJ, Chung Y, Dong C (2012) Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation. Proc Natl Acad Sci U S A 109:13064\u201313069","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14_CR25","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.immuni.2010.04.010","volume":"32","author":"JM Reynolds","year":"2010","unstructured":"Reynolds JM et al (2010) Toll-like receptor 2 signaling in CD4+ T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease. Immunity 32:692\u2013702","journal-title":"Immunity"},{"key":"14_CR26","doi-asserted-by":"publisher","first-page":"932530","DOI":"10.3389\/fpain.2022.932530","volume":"3","author":"AJ Kwilasz","year":"2022","unstructured":"Kwilasz AJ et al (2022) Involvement of TLR2\u2013TLR4, NLRP3, and IL-17 in pain induced by a novel Sprague-Dawley rat model of experimental autoimmune encephalomyelitis. Front Pain Res (Lausanne) 3:932530","journal-title":"Front Pain Res (Lausanne)"},{"key":"14_CR27","doi-asserted-by":"publisher","first-page":"112896","DOI":"10.1016\/j.bbr.2020.112896","volume":"396","author":"AJ Kwilasz","year":"2021","unstructured":"Kwilasz AJ et al (2021) Experimental autoimmune encephalopathy (EAE)-induced hippocampal neuroinflammation and memory deficits are prevented with the non-opioid TLR2\/TLR4 antagonist (+)-naltrexone. Behav Brain Res 396:112896","journal-title":"Behav Brain Res"},{"key":"14_CR28","doi-asserted-by":"publisher","first-page":"7505","DOI":"10.4049\/jimmunol.177.11.7505","volume":"177","author":"T Touil","year":"2006","unstructured":"Touil T, Fitzgerald D, Zhang G-X, Rostami A, Gran B (2006) Cutting edge: TLR3 stimulation suppresses experimental autoimmune encephalomyelitis by inducing endogenous IFN-\u03b2. J Immunol 177:7505\u20137509","journal-title":"J Immunol"},{"key":"14_CR29","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jneuroim.2005.11.006","volume":"172","author":"BS Hansen","year":"2006","unstructured":"Hansen BS, Hussain RZ, Lovett-Racke AE, Thomas JA, Racke MK (2006) Multiple toll-like receptor agonists act as potent adjuvants in the induction of autoimmunity. J Neuroimmunol 172:94\u2013103","journal-title":"J Neuroimmunol"},{"key":"14_CR30","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1172\/JCI33342","volume":"118","author":"B Guo","year":"2008","unstructured":"Guo B, Chang EY, Cheng G (2008) The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice. J Clin Invest 118:1680\u20131690","journal-title":"J Clin Invest"},{"key":"14_CR31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00401-015-1418-z","volume":"130","author":"R Khorooshi","year":"2015","unstructured":"Khorooshi R et al (2015) Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis. Acta Neuropathol 130:107\u2013118","journal-title":"Acta Neuropathol"},{"key":"14_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.clim.2013.10.012","volume":"150","author":"M Saresella","year":"2014","unstructured":"Saresella M et al (2014) Toll-like receptor 3 differently modulates inflammation in progressive or benign multiple sclerosis. Clin Immunol 150:109\u2013120","journal-title":"Clin Immunol"},{"key":"14_CR33","doi-asserted-by":"publisher","first-page":"685645","DOI":"10.3389\/fnins.2021.685645","volume":"15","author":"RS Dieu","year":"2021","unstructured":"Dieu RS et al (2021) Central nervous system-endogenous TLR7 and TLR9 induce different immune responses and effects on experimental autoimmune encephalomyelitis. Front Neurosci 15:685645","journal-title":"Front Neurosci"},{"key":"14_CR34","doi-asserted-by":"publisher","first-page":"68245","DOI":"10.3389\/fnins.2021.682451","volume":"15","author":"M Dubik","year":"2021","unstructured":"Dubik M et al (2021) Innate signaling in the CNS prevents demyelination in a focal EAE model. Front Neurosci 15:68245","journal-title":"Front Neurosci"},{"key":"14_CR35","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/eji.201242985","volume":"44","author":"PH Lalive","year":"2014","unstructured":"Lalive PH et al (2014) TLR7 signaling exacerbates CNS autoimmunity through downregulation of Foxp3+ Treg cells. Eur J Immunol 44:46\u201357","journal-title":"Eur J Immunol"},{"key":"14_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jneuroim.2016.07.019","volume":"298","author":"Y Tao","year":"2016","unstructured":"Tao Y, Zhang X, Markovic-Plese S (2016) Toll-like receptor (TLR)7 and TLR9 agonists enhance interferon (IFN) beta-1a\u2019s immunoregulatory effects on B cells in patients with relapsing-remitting multiple sclerosis (RRMS). J Neuroimmunol 298:181\u2013188","journal-title":"J Neuroimmunol"},{"key":"14_CR37","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/ana.22136","volume":"68","author":"KE Balashov","year":"2010","unstructured":"Balashov KE, Aung LL, Vaknin-Dembinsky A, Dhib-Jalbut S, Weiner HL (2010) Interferon-\u03b2 inhibits toll-like receptor 9 processing in multiple sclerosis. Ann Neurol 68:899\u2013906","journal-title":"Ann Neurol"},{"key":"14_CR38","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.it.2006.06.005","volume":"27","author":"RPM Sutmuller","year":"2006","unstructured":"Sutmuller RPM, Morgan ME, Netea MG, Grauer O, Adema GJ (2006) Toll-like receptors on regulatory T cells: expanding immune regulation. Trends Immunol 27:387\u2013393","journal-title":"Trends Immunol"},{"key":"14_CR39","first-page":"Unit\u201315.1","volume":"CHAPTER 15","author":"SD Miller","year":"2010","unstructured":"Miller SD, Karpus WJ, Davidson TS (2010) Experimental autoimmune encephalomyelitis in the mouse. Curr Protoc Immunol CHAPTER 15:Unit\u201315.1","journal-title":"Curr Protoc Immunol"},{"key":"14_CR40","doi-asserted-by":"publisher","first-page":"556391","DOI":"10.3389\/fphar.2020.556391","volume":"11","author":"M Kim","year":"2020","unstructured":"Kim M et al (2020) Oleanolic acid acetate alleviates symptoms of experimental autoimmune encephalomyelitis in mice by regulating toll-like receptor 2 signaling. Front Pharmacol 11:556391","journal-title":"Front Pharmacol"},{"key":"14_CR41","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3390\/cells9040843","volume":"9","author":"J Zhan","year":"2020","unstructured":"Zhan J et al (2020) The cuprizone model: dos and do nots. Cell 9:843","journal-title":"Cell"},{"key":"14_CR42","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.3988","volume":"11","author":"J Wu","year":"2021","unstructured":"Wu J et al (2021) Transcardiac perfusion of the mouse for brain tissue dissection and fixation. Bio Protoc 11:e3988","journal-title":"Bio Protoc"},{"key":"14_CR43","doi-asserted-by":"publisher","first-page":"109562","DOI":"10.1016\/j.intimp.2022.109562","volume":"114","author":"S Ying","year":"2023","unstructured":"Ying S et al (2023) The small-molecule compound baicalein alleviates experimental autoimmune encephalomyelitis by suppressing pathogenetic CXCR6+ CD4 cells. Int Immunopharmacol 114:109562","journal-title":"Int Immunopharmacol"},{"key":"14_CR44","doi-asserted-by":"publisher","first-page":"22594","DOI":"10.1038\/s41598-021-01963-3","volume":"11","author":"LM Toomey","year":"2021","unstructured":"Toomey LM et al (2021) Cuprizone feed formulation influences the extent of demyelinating disease pathology. Sci Rep 11:22594","journal-title":"Sci Rep"},{"key":"14_CR45","doi-asserted-by":"publisher","first-page":"103763","DOI":"10.1016\/j.isci.2022.103763","volume":"25","author":"M Tredicine","year":"2022","unstructured":"Tredicine M et al (2022) A TLR\/CD44 axis regulates T cell trafficking in experimental and human multiple sclerosis. iScience 25:103763","journal-title":"iScience"},{"key":"14_CR46","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3109\/08916934.2016.1141898","volume":"49","author":"MG Evangelista","year":"2016","unstructured":"Evangelista MG et al (2016) Early IFN-\u03b3 production together with decreased expression of TLR3 and TLR9 characterizes EAE development conditional on the presence of myelin. Autoimmunity 49:258\u2013267","journal-title":"Autoimmunity"},{"key":"14_CR47","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1172\/JCI26078","volume":"116","author":"M Prinz","year":"2006","unstructured":"Prinz M et al (2006) Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J Clin Invest 116:456\u2013464","journal-title":"J Clin Invest"}],"container-title":["Methods in Molecular Biology","Toll-Like Receptors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3366-3_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T14:04:11Z","timestamp":1692626651000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3366-3_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9781071633656","9781071633663"],"references-count":47,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3366-3_14","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"22 August 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}